| AlloCure's Investigational Treatment for Acute Kidney Injury Receives Fast ... - MarketWatch (press release) |
|
|
MarketWatch (press release) Following the completion of a successful Phase 1 trial, which was presented in November 2011 at the annual meeting of the American Society of Nephrology, AlloCure plans to initiate a Phase 2 study of AC607 in the first half of 2012. |